Search Results

Inclusion of medicines with Risk Minimisation Measures (RMM) in Patient Group Directions

16 March 2021This Q&A has been developed with the MHRA and it reflects MHRA guidance on the use of PGDs for medications which have risk minimisation measures (RMM).

Mixing of medicines and Patient Group Directions

9 September 2020This Q&A provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD

Off-label medicine use under a Patient Group Direction

10 June 2021The below summary explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label')

Off-label or unlicensed products and Schedule 17 of the Human Medicines Regulations 2012 exemptions

8 January 2020The below summary details the legal position regarding the sale, supply or administration of off-label/ unlicenced products under Schedule 17 of the HMR 2012

Patient Group Direction use in End of Life Care

10 August 2020Questions are frequently asked around the use of Patient Group Direction (PGDs) use in End of Life Care (EoLC). As with any other patient pathway…

Supply and/or administration of Controlled Drugs under a Patient Group Direction

16 November 2021This Q&A summarises the legal position on the supply and/or administration of controlled drugs under PGDs.

Supply and/or administration of abortifacients under Patient Group Directions

14 September 2020This Q&A advises on the legal position on the supply/administration of abortifacients under PGDs.

Unlicensed medicines and use of PGDs

16 November 2021This page explains why PGD are not legal mechanism for the administration or supply of unlicensed medicines.

Using a Patient Group Direction to adjust doses of medicines

16 November 2021This article outlines why PGDs cannot be used to adjust the dosage of a medicine already in an individual's possession

SPS - Specialist Pharmacy Service

NHS

Administering, Supply

9 results